Six months of therapy with clenbuterol, an bronchial asthma treatment, slowed illness development in adults with amyotrophic lateral sclerosis (ALS), based on knowledge from a
Spectral Medical Inc. Experiences important uptick in enrollment actions Tigris trial enrollment at 61 sufferers TORONTO, Might 30, 2023 (GLOBE NEWSWIRE) — Spectral Medical Inc.
NGS creates a sport dietary complement, targets adolescent athletes TEL AVIV, Israel, Jan. 11, 2023 /PRNewswire/ — Dietary Progress Options, Ltd., (ASX:NGS), a number one
The medical trial group contains, from left, Gordon Bernard, MD, Katherine Cahill, MD, Kevin Niswender, MD, PhD, Pingsheng Wu, PhD, and R. Stokes Peebles, MD.
View More